This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06908/identifier/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06908/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06908/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06908/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB06908/identifier/pubchem-substance/

Statements

Subject Item
n2:DB06908
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB06908 n14:DB06908
dcterms:title
(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
adms:identifier
n4:99443379 n7:208 n8:9549225 n9:7828145 n12:DB06908
n5:IUPAC-Name
n6:271B5DA1-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5DA7-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5DA6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5DA3-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5DA4-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5DA5-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5D9F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5DA0-363D-11E5-9242-09173F13E4C5 n6:271B5D9D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5D9E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5DAD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5DAE-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5DA8-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5DA9-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5DAB-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5DAA-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5DAC-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5DB3-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5DB5-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5DB6-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5DB2-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5DB1-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5DB4-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5DA2-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5DAF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5DB0-363D-11E5-9242-09173F13E4C5